ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $17,000 | -10.5% | 11,767 | -10.9% | 0.00% | 0.0% |
| Q4 2016 | $19,000 | -5.0% | 13,202 | +14.2% | 0.00% | 0.0% |
| Q3 2016 | $20,000 | -97.7% | 11,562 | -92.1% | 0.00% | -97.4% |
| Q2 2014 | $859,000 | -24.7% | 146,511 | -19.1% | 0.04% | -26.9% |
| Q1 2014 | $1,141,000 | +34.7% | 181,051 | +25.1% | 0.05% | +36.8% |
| Q4 2013 | $847,000 | +40.7% | 144,767 | +26.7% | 0.04% | +18.8% |
| Q3 2013 | $602,000 | -29.0% | 114,291 | +3.8% | 0.03% | -46.7% |
| Q2 2013 | $848,000 | – | 110,102 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |